HIGHLIGHTS
- who: Yanhui Wan from the Second People`s Hospital, Futian Road, Shenzhen, China have published the paper: Prognostic value of Beclin 1, EGFR and ALK in non-squamous non-small cell lung cancer, in the Journal: (JOURNAL)
- what: The study was carried out to investigate the prognostic value of 1 and for this cancer. The authors analyzed the expression and mutation of Beclin 1, EGFR and ALK in patients with non-squamous NSCLC and their relationship with postoperative survival. This study was approved by the ethical committee of Shenzhen University and written informed consent was . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.